Geovax Labs Inc

NASDAQ:GOVX 4:00:00 PM EDT

0.69

0.00 (+0.73%)

5:05:05 PM EDT: $0.70 +0.01 (+1.75%)

Market Cap (Intraday)	17.36M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.33 Million
Adjusted EPS	-$0.33

See more estimates

10-Day MA	$0.68
50-Day MA	$0.93
200-Day MA	$1.66

See more pivots

Geovax Labs Inc Stock, NASDAQ:GOVX

1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080

United States of America

Phone: +1.678.384.7220

Number of Employees: 17

http://www.geovax.com

Description

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.